Hypoxia-Inducible Factors Activate CD133 Promoter through ETS Family Transcription Factors
2013
CD133 is a cellular surface protein that has been reported to be a cancer stem cell marker, and thus it is considered to be a potential target for cancer treatment. However, the mechanism regulating CD133 expression is not yet understood. In this study, we analyzed the activity of five putative promoters (P1–P5) of CD133 in human embryonic kidney (HEK) 293 cells and colon cancer cell line WiDr, and found that the activity of promoters, particularly of P5, is elevated by overexpression of hypoxia-inducible factors (HIF-1a and HIF-2a). Deletion and mutation analysis identified one of the two E-twenty six (ETS) binding sites (EBSs) in the P5 region as being essential for its promoter activity induced by HIF-1a and HIF-2a. In addition, a chromatin imunoprecipitation assay demonstrated that HIF-1a and HIF-2a bind to the proximal P5 promoter at the EBSs. The immunoprecipitation assay showed that HIF-1a physically interacts with Elk1; however, HIF-2a did not bind to Elk1 or ETS1. Furthermore, knockdown of both HIF-1a and HIF-2a resulted in a reduction of CD133 expression in WiDr. Taken together, our results revealed that HIF-1a and HIF-2a activate CD133 promoter through ETS proteins.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
34
References
27
Citations
NaN
KQI